The Coca-Cola Company Today Announced Dr. Helene D. Gayle, M.D., M.P.H., President And CEO Of CARE USA, Has Been Nominated To Stand For Election To The Company's Board Of Directors At Its Annual Meeting Of Shareowners In April. (Photo: Business Wire)
The Coca-Cola Company today announced Helene D. Gayle, M.D., M.P.H., has been nominated to stand for election to the Company’s Board of Directors at its Annual Meeting of Shareowners in April. Dr. Gayle, 57, is President and CEO of CARE USA, a leading international humanitarian organization whose poverty fighting programs reached approximately 122 million people last year in 84 countries.
An expert on health, global development and humanitarian issues, Dr. Gayle spent 20 years with the Centers for Disease Control, working primarily on HIV/AIDS and has worked at the Bill & Melinda Gates Foundation, directing programs on HIV/AIDS and other global health issues.
Dr. Gayle is a member of the Council on Foreign Relations, the American Public Health Association, the Institute of Medicine and the American Academy of Pediatrics. She currently serves on the President's Commission on White House Fellowships and the U.S. Department of State's Foreign Affairs Policy Board.
“Helene brings a global mindset and a deep understanding of health and humanitarian issues to our Company,” said Muhtar Kent, Chairman and CEO, The Coca-Cola Company. “Her expertise and insight will be invaluable as we continue to expand our global initiatives around sustainability and women.”
Named one of Forbes' "100 Most Powerful Women," and Foreign Policy magazine's "Top 100 Global Thinkers," Dr. Gayle earned a B.A. in psychology at Barnard College, an M.D. from the University of Pennsylvania and an M.P.H. from Johns Hopkins University.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
